Huron Consulting Group Inc

Huron Consulting Group Inc(HURN)股票分析

$198.480

+2.838 (+1.43%)收盤時

Loading chart…
最高
202.030
開盤
194.330
成交量加權均價
198.28
成交量
425.52K
市值
1.76B
最低
194.330
成交金額
84.37M
企業價值/稅息折舊攤銷前利潤(TTM)
14.24

Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions.

AI 分析 of Huron Consulting Group Inc (HURN)

買進

Huron Consulting Group Inc is a good buy right now due to its strong recent performance and positive outlook. The current price is $195.69, and the stock has shown a remarkable 11.91% increase over the last 5 days and a 23.87% increase over the last 20 days. Additionally, the forward P/E ratio is 14.51, indicating potential undervaluation compared to its growth prospects. However, the main risk is the significant insider selling, which has increased by 196.55% over the last month, suggesting potential concerns among insiders about the stock's future performance.

分析師評級(4)

上檔空間 +6.31%
買進
2 買進
2 持有
0 賣出
目前: 198.48
最低
207.00
平均
211.00
最高
215.00

Benchmark

2026-06-23

目標價

$215

買進

Benchmark

2025-12-24

目標價

$215

買進

Truist

2025-11-14

目標價

$240

買進

Barrington

2025-10-30

目標價

$190

優於大盤

Barrington

2025-08-07

目標價

$176

優於大盤

估值指標

Huron Consulting Group Inc(HURN)目前預期本益比為 14.51,5 年平均預期本益比為 17.68。

預期本益比

低估
5 年均值 P/E
17.68
目前P/E
14.51
高估
20.20
低估
15.17

預期 EV/EBITDA

嚴重高估
5 年均值 EV/EBITDA
11.48
目前EV/EBITDA
14.24
高估
12.61
低估
10.34

預期股價營收比

嚴重高估
5 年均值 P/S
1.17
目前P/S
1.53
高估
1.34
低估
0.99

Alphio AI 對 HURN 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%HURN

$200.76

情境價格

基

基準

基準 · 50%HURN

$171.26

情境價格

悲

悲觀

悲觀 · 25%HURN

$156.74

情境價格

持有 HURN 的大戶

I

Invenomic Capital Management LP

+ 持有HURN

+4.64%

3個月報酬率

事件時間軸

2026-07-28 (ET)

16:30:00

Huron Reports Q2 Revenue of $465.6M, Beating Expectations

16:30:00

Sees FY26 Revenue at $1.85B-$1.89B

2026-06-22 (ET)

09:30:00

Huron Appoints Shoshana Vernick to Board of Directors

2026-06-03 (ET)

09:50:00

Huron Acquires RelateCare to Strengthen Healthcare Services

2026-05-05 (ET)

17:10:00

Affirms FY26 Revenue at $1.78B-$1.86B

資訊

HURN 常見問題 —— 由 Alphio AI 解答

Huron Consulting Group Inc. is a global professional service. The Company operates in three segments: Healthcare, Education, and Commercial. The Healthcare segment serves acute care providers, including national and regional health systems; academic health systems; community health systems; the federal health system; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment serves public and private colleges and universities, research institutes, not-for-profit organizations and other education-related organizations. The Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Its products include TriZetto’s Facets, QNXT, and HealthEdge solutions. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Huron Consulting Group Inc is a good buy right now due to its strong recent performance and positive outlook. The current price is $195.69, and the stock has shown a remarkable 11.91% increase over the last 5 days and a 23.87% increase over the last 20 days. Additionally, the forward P/E ratio is 14.51, indicating potential undervaluation compared to its growth prospects. However, the main risk is the significant insider selling, which has increased by 196.55% over the last month, suggesting potential concerns among insiders about the stock's future performance.

4 analysts cover HURN: 2 rate it Buy, 2 Hold and 0 Sell. The average price target is 211.00.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易